Vitamin D and hypertension: Prospective study and meta-analysis.

OBJECTIVES:The study sought to determine the link between vitamin D concentrations and incident hypertension in prospective study and meta-analysis. METHODS:The study was embedded in the Kailuan Study, a population-based cohort of adults that contains underground miners. In 2012, we studied 2,456 me...

Full description

Bibliographic Details
Main Authors: Dan Qi, Xiao-Lu Nie, Shouling Wu, Jun Cai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5373576?pdf=render
_version_ 1828886026155720704
author Dan Qi
Xiao-Lu Nie
Shouling Wu
Jun Cai
author_facet Dan Qi
Xiao-Lu Nie
Shouling Wu
Jun Cai
author_sort Dan Qi
collection DOAJ
description OBJECTIVES:The study sought to determine the link between vitamin D concentrations and incident hypertension in prospective study and meta-analysis. METHODS:The study was embedded in the Kailuan Study, a population-based cohort of adults that contains underground miners. In 2012, we studied 2,456 men and women free of prevalent hypertension, age 21 to 67 at baseline. Serum 25-hydroxyvitamin D was measured from previously frozen baseline samples using ELISA (Enzyme-Linked ImmunoadSorbent Assay). We use the logistic regression analysis to estimate the odd radio (ORs) 95% confidence intervals (CIs) for 25-hydroxyvitamin D [25(OH)D] concentrations with incident hypertension. To help place our new data in context, we conducted a systemic review and meta-analysis of previous prospective reports of vitamin D and hypertension. RESULTS:During a median follow-up of 2 years, 42.6% of the cohort (n = 1047) developed hypertension. Compared with the 25-hydroxyvitamin D >30ng/ml, 25-hydroxyvitamin D <20 ng/ml was associated with a greater hypertension risk (OR: 1.225 [95% CI: 1.010 to 1.485] p = 0.04), although the association was attenuated and not statistically significant after adjusting for potential confounders (OR: 1.092 [95% CI: 0.866 to 1.377] p = 0.456). This meta-analysis included seven prospective studies for 53,375 participants using adjusted HR founded a significant association between vitamin D deficiencies and incident hypertension (HRs = 1.235 (95% CI: 1.083 to 1.409, p = 0.002)). CONCLUSION:Lower serum 25-hydroxyvitamin D concentrations were not associated with a greater risk of incident hypertension. More research is needed to further determine the role of 25-hydroxyvitamin D in hypertension prevention and therapy.
first_indexed 2024-12-13T11:37:56Z
format Article
id doaj.art-34b843571f034608a228cb7324b502bd
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T11:37:56Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-34b843571f034608a228cb7324b502bd2022-12-21T23:47:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01123e017429810.1371/journal.pone.0174298Vitamin D and hypertension: Prospective study and meta-analysis.Dan QiXiao-Lu NieShouling WuJun CaiOBJECTIVES:The study sought to determine the link between vitamin D concentrations and incident hypertension in prospective study and meta-analysis. METHODS:The study was embedded in the Kailuan Study, a population-based cohort of adults that contains underground miners. In 2012, we studied 2,456 men and women free of prevalent hypertension, age 21 to 67 at baseline. Serum 25-hydroxyvitamin D was measured from previously frozen baseline samples using ELISA (Enzyme-Linked ImmunoadSorbent Assay). We use the logistic regression analysis to estimate the odd radio (ORs) 95% confidence intervals (CIs) for 25-hydroxyvitamin D [25(OH)D] concentrations with incident hypertension. To help place our new data in context, we conducted a systemic review and meta-analysis of previous prospective reports of vitamin D and hypertension. RESULTS:During a median follow-up of 2 years, 42.6% of the cohort (n = 1047) developed hypertension. Compared with the 25-hydroxyvitamin D >30ng/ml, 25-hydroxyvitamin D <20 ng/ml was associated with a greater hypertension risk (OR: 1.225 [95% CI: 1.010 to 1.485] p = 0.04), although the association was attenuated and not statistically significant after adjusting for potential confounders (OR: 1.092 [95% CI: 0.866 to 1.377] p = 0.456). This meta-analysis included seven prospective studies for 53,375 participants using adjusted HR founded a significant association between vitamin D deficiencies and incident hypertension (HRs = 1.235 (95% CI: 1.083 to 1.409, p = 0.002)). CONCLUSION:Lower serum 25-hydroxyvitamin D concentrations were not associated with a greater risk of incident hypertension. More research is needed to further determine the role of 25-hydroxyvitamin D in hypertension prevention and therapy.http://europepmc.org/articles/PMC5373576?pdf=render
spellingShingle Dan Qi
Xiao-Lu Nie
Shouling Wu
Jun Cai
Vitamin D and hypertension: Prospective study and meta-analysis.
PLoS ONE
title Vitamin D and hypertension: Prospective study and meta-analysis.
title_full Vitamin D and hypertension: Prospective study and meta-analysis.
title_fullStr Vitamin D and hypertension: Prospective study and meta-analysis.
title_full_unstemmed Vitamin D and hypertension: Prospective study and meta-analysis.
title_short Vitamin D and hypertension: Prospective study and meta-analysis.
title_sort vitamin d and hypertension prospective study and meta analysis
url http://europepmc.org/articles/PMC5373576?pdf=render
work_keys_str_mv AT danqi vitamindandhypertensionprospectivestudyandmetaanalysis
AT xiaolunie vitamindandhypertensionprospectivestudyandmetaanalysis
AT shoulingwu vitamindandhypertensionprospectivestudyandmetaanalysis
AT juncai vitamindandhypertensionprospectivestudyandmetaanalysis